Medical Technology

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 4 years ago

Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More

@xconomy.com 4 years ago

Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits

@xconomy.com 5 years ago

CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M

@xconomy.com 5 years ago

After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals

@xconomy.com 5 years ago

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

@xconomy.com 5 years ago

ResMed Boosts Connected Health Play With $225M Propeller Health Deal

@xconomy.com 5 years ago

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

@xconomy.com 5 years ago

With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?

@xconomy.com 5 years ago

Quest Analytics Buys Healthcare Compliance Software Firm BetterDoctor

@xconomy.com 5 years ago

Fictiv Raises $15M To Connect Tech Innovators & Parts Manufacturers

@xconomy.com 6 years ago

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs